Showing 9 of 9 recruiting trials for “malignant-triton-tumor”
DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma
👨⚕️ Salah-Eddin Al-Batran, Prof. Dr., Frankfurter Institut für Klinische Krebsforschung IKF GmbH📍 2 sites📅 Started Dec 2025View details ↗
Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
👨⚕️ Michiel S. van der Heijden, PhD, The Netherlands Cancer Institute📍 2 sites📅 Started Aug 2024View details ↗
Enrolling by InvitationNCT06565585 ↗
Prediction of Local Recurrence and Its Impact on Long-term Outcomes After Low-risk Glans-sparing Surgery for Penile Squamous Cell Carcinoma
TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer
FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer
Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
RecruitingNCT05447273 ↗
The Role of Functional Magnetic Resonance Imaging in Preoperative Assessment of Primary Penile Carcinoma
RecruitingNCT05264337 ↗
Lymphedema After Urologic Surgery
👨⚕️ Henrik Kjölhede, MD, PhD, Sahlgrenska University Hospital, Gothenburg University📍 2 sites📅 Started Mar 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →